Walleye Capital
GMED icon

Walleye Capital’s Globus Medical GMED Stock Holding History

Walleye Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
156,421
+156,394
+579,237% +$13.3M 0.04% 395
2026
Q1 		$2.33K Sell
27
-818,829
-100% -$73.5M ﹤0.01% 4230
2025
Q4 		$71.5M Buy
818,856
+62,635
+8% +$4.75M 0.22% 32
2025
Q3 		$43.3M Buy
756,221
+440,151
+139% +$25.3M 0.16% 78
2025
Q2 		$18.7M Sell
316,070
-41,451
-12% -$2.68M 0.07% 260
2025
Q1 		$26.2M Buy
357,521
+138,964
+64% +$11.5M 0.12% 139
2024
Q4 		$18.1M Sell
218,557
-26,942
-11% -$2.12M 0.04% 364
2024
Q3 		$17.6M Buy
245,499
+60,478
+33% +$4.27M 0.04% 396
2024
Q2 		$12.7M Sell
185,021
-61,700
-25% -$3.69M 0.02% 613
2024
Q1 		$13.2M Buy
246,721
+3,942
+2% +$212K 0.02% 656
2023
Q4 		$12.9M Sell
242,779
-8,441
-3% -$411K 0.03% 547
2023
Q3 		$12.5M Buy
251,220
+61,526
+32% +$3.44M 0.03% 455
2023
Q2 		$11.3M Buy
189,694
+76,977
+68% +$4.39M 0.04% 347
2023
Q1 		$6.38M Sell
112,717
-57,373
-34% -$3.68M 0.1% 261
2022
Q4 		$12.6M Sell
170,090
-66,258
-28% -$4.51M 0.23% 90
2022
Q3 		$14.1M Buy
236,348
+174,251
+281% +$10.5M 0.27% 59
2022
Q2 		$3.49M Sell
62,097
-93,629
-60% -$6.15M 0.1% 234
2022
Q1 		$11.5M Buy
155,726
+42,211
+37% +$2.93M 0.31% 59
2021
Q4 		$8.2M Buy
113,515
+52,031
+85% +$3.78M 0.25% 83
2021
Q3 		$4.71M Sell
61,484
-14,596
-19% -$1.17M 0.13% 97
2021
Q2 		$5.9M Buy
76,080
+7,000
+10% +$498K 0.2% 67
2021
Q1 		$4.26M Buy
69,080
+18,055
+35% +$1.14M 0.25% 60
2020
Q4 		$3.33M Buy
+51,025
New +$2.93M 0.22% 72

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Walleye Capital's GMED Position: Q2 2026 in Review

Walleye Capital increased its Globus Medical (GMED) stake by 579,237% in Q2 2026, buying an estimated $13.3M and bringing the position to 156,421 shares worth $12.4M. The position accounts for 0.04% of the portfolio, ranked #395.

Walleye Capital first reported a position in GMED in Q4 2020 and has held it in 23 quarters since. The position peaked at $71.5M in Q4 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Walleye Capital held 156,421 shares of Globus Medical worth $12.4M as of Q2 2026.
  • Walleye Capital bought 156,394 Globus Medical shares in Q2 2026, an estimated $13.3M.
  • Globus Medical made up 0.04% of Walleye Capital's portfolio in Q2 2026, its #395 holding.
  • Walleye Capital first reported a position in Globus Medical in Q4 2020 and has held it in 23 quarters since.
  • Walleye Capital's Globus Medical position peaked at $71.5M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.